Basit öğe kaydını göster

dc.contributor.authorCelik, Orcun
dc.contributor.authorEkin, Gokhan
dc.contributor.authorIpekci, Tumay
dc.contributor.authorBudak, Salih
dc.contributor.authorIlbey, Yusuf Ozlem
dc.date.accessioned2019-09-19T12:27:46Z
dc.date.available2019-09-19T12:27:46Z
dc.date.issued2016
dc.identifier.issn1124-3562
dc.identifier.urihttps://www.pagepressjournals.org/index.php/aiua/article/view/5915
dc.identifier.urihttp://hdl.handle.net/11727/3968
dc.description.abstractSmall cell bladder carcinoma is a rare and frequently fatal disease. It can be distinguished from classical urothelial carcinoma microscopically and immunohistochemically. Small cell bladder carcinoma has histologically similar properties with other small cell carcinomas in other organs. It has a worse prognosis when compared to urothelial bladder cancer. Multimodal treatments are recommended although there is no widely accepted consensus regarding to the treatment algorithm because of its rarity. In this review, clinical properties and diagnosis of small cell bladder carcinoma, its histopathological and immunohistochemical properties and treatment modalities are examined.en_US
dc.language.isoengen_US
dc.relation.isversionof10.4081/aiua.2016.1.52en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeuroendocrine carcinomaen_US
dc.subjectBladder canceren_US
dc.subjectSmall cell canceren_US
dc.titleDiagnosis and treatment in primary bladder small cell carcinoma: Literature reviewen_US
dc.typereviewen_US
dc.relation.journalARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIAen_US
dc.identifier.volume88en_US
dc.identifier.issue1en_US
dc.identifier.startpage52en_US
dc.identifier.endpage55en_US
dc.identifier.wos000406050000010en_US
dc.identifier.scopus2-s2.0-84977766693en_US
dc.contributor.pubmedID27072176en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster